JPH0564124B2 - - Google Patents

Info

Publication number
JPH0564124B2
JPH0564124B2 JP59081001A JP8100184A JPH0564124B2 JP H0564124 B2 JPH0564124 B2 JP H0564124B2 JP 59081001 A JP59081001 A JP 59081001A JP 8100184 A JP8100184 A JP 8100184A JP H0564124 B2 JPH0564124 B2 JP H0564124B2
Authority
JP
Japan
Prior art keywords
alkyl
formulation according
codergocline
hydroxy
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59081001A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59205318A (ja
Inventor
Berutsueru Deiitaa
Byuuruman Hansu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS59205318A publication Critical patent/JPS59205318A/ja
Publication of JPH0564124B2 publication Critical patent/JPH0564124B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP59081001A 1983-04-22 1984-04-20 コデルゴクリンとカルシウム拮抗剤からなる製剤 Granted JPS59205318A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3314607 1983-04-22
DE3314607.1 1983-04-22

Publications (2)

Publication Number Publication Date
JPS59205318A JPS59205318A (ja) 1984-11-20
JPH0564124B2 true JPH0564124B2 (en:Method) 1993-09-14

Family

ID=6197070

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59081001A Granted JPS59205318A (ja) 1983-04-22 1984-04-20 コデルゴクリンとカルシウム拮抗剤からなる製剤

Country Status (27)

Country Link
US (2) US4617306A (en:Method)
JP (1) JPS59205318A (en:Method)
AT (1) AT393625B (en:Method)
AU (1) AU571218B2 (en:Method)
BE (1) BE899434A (en:Method)
CA (1) CA1218932A (en:Method)
CH (1) CH658992A5 (en:Method)
CY (1) CY1499A (en:Method)
DD (1) DD217712A5 (en:Method)
DK (1) DK165965C (en:Method)
FR (1) FR2544614B1 (en:Method)
GB (1) GB2138678B (en:Method)
GR (1) GR81973B (en:Method)
HK (1) HK100289A (en:Method)
HU (1) HU192050B (en:Method)
IE (1) IE57468B1 (en:Method)
IL (1) IL71601A (en:Method)
IT (1) IT1199114B (en:Method)
LU (1) LU85331A1 (en:Method)
MY (1) MY100397A (en:Method)
NL (1) NL188891C (en:Method)
NZ (1) NZ207917A (en:Method)
PH (1) PH20922A (en:Method)
PT (1) PT78455B (en:Method)
SE (1) SE465751B (en:Method)
SG (1) SG53889G (en:Method)
ZA (1) ZA842993B (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740365A (en) * 1984-04-09 1988-04-26 Toyo Boseki Kabushiki Kaisha Sustained-release preparation applicable to mucous membrane in oral cavity
ATE400251T1 (de) * 1999-02-09 2008-07-15 Pfizer Prod Inc Zusammensetzungen basischer arzneistoffe mit verbesserter bioverfügbarkeit
US6209563B1 (en) 2000-01-07 2001-04-03 Saturn Electronics & Engineering, Inc. Solenoid control valve
US6581634B2 (en) 2000-01-10 2003-06-24 Saturn Electronics & Engineering, Inc. Solenoid control valve with particle gettering magnet
US6321767B1 (en) 2000-01-10 2001-11-27 Saturn Electronics & Engineering, Inc. High flow solenoid control valve
US20090166274A1 (en) * 2007-05-24 2009-07-02 Eaton Corporation Engine valve with a combined engine oil filter and valve actuator solenoid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5468M (en:Method) * 1966-06-24 1967-10-16
SE351565B (en:Method) * 1967-08-17 1972-12-04 Sandoz Ag
FI761461A7 (en:Method) * 1975-05-31 1976-12-01 Sandoz Ag
JPS5487177A (en) * 1977-12-23 1979-07-11 Fujitsu Ltd Component positioning unit
DK154607C (da) * 1978-12-21 1989-06-05 Sandoz Ag Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider
DE2930369A1 (de) * 1979-07-26 1981-02-05 Rentschler Arzneimittel Arzneimittelloesungen
GB2063670A (en) * 1979-11-28 1981-06-10 Sandoz Products Ltd Ergots and their use in treating minimal brain dysfunction

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE MERCK INDEX IOTH EDI=1983 *

Also Published As

Publication number Publication date
HUT37889A (en) 1986-03-28
IE57468B1 (en) 1993-01-27
SE8402199L (sv) 1984-10-23
PT78455B (en) 1986-05-27
LU85331A1 (fr) 1984-11-28
HU192050B (en) 1987-05-28
DD217712A5 (de) 1985-01-23
BE899434A (fr) 1984-10-16
SE465751B (sv) 1991-10-28
FR2544614A1 (fr) 1984-10-26
IL71601A (en) 1988-12-30
FR2544614B1 (fr) 1987-08-21
HK100289A (en) 1989-12-29
DK201884D0 (da) 1984-04-18
CA1218932A (en) 1987-03-10
GB8410363D0 (en) 1984-05-31
SG53889G (en) 1989-12-08
ZA842993B (en) 1985-11-27
DK201884A (da) 1984-10-23
DK165965C (da) 1993-07-26
GB2138678A (en) 1984-10-31
GR81973B (en:Method) 1984-12-12
AU571218B2 (en) 1988-04-14
CY1499A (en) 1990-08-03
GB2138678B (en) 1986-11-05
IT8448082A1 (it) 1985-10-20
JPS59205318A (ja) 1984-11-20
IT8448082A0 (it) 1984-04-20
PH20922A (en) 1987-06-05
MY100397A (en) 1990-09-17
NZ207917A (en) 1988-05-30
IL71601A0 (en) 1984-07-31
DK165965B (da) 1993-02-22
PT78455A (en) 1984-05-01
SE8402199D0 (sv) 1984-04-19
NL188891C (nl) 1992-11-02
IT1199114B (it) 1988-12-30
NL8401155A (nl) 1984-11-16
CH658992A5 (de) 1986-12-31
AT393625B (de) 1991-11-25
US4617306A (en) 1986-10-14
AU2712084A (en) 1984-10-25
US4797404A (en) 1989-01-10
IE840977L (en) 1984-10-22
ATA133784A (de) 1991-05-15

Similar Documents

Publication Publication Date Title
TW202120484A (zh) 口服補體因子d抑制劑之給藥方案
JP2007518755A (ja) モノアミン神経伝達物質再取り込み阻害剤及びｎ−メチル−ｄ−アスパラギン酸（ｎｍｄａ）受容体アンタゴニストを含む医薬組成物
JP2011514379A (ja) 選択的ｓ１ｐ１レセプターアゴニストの投与法
JP2007508336A (ja) モノアミン神経伝達物質再取り込みインヒビター及びアセチルコリンエステラーゼインヒビターを含む医薬組成物
EA003142B1 (ru) Лекарственное средство, обладающее антидепрессивным действием, его применение и способ лечения
RU2286784C2 (ru) Таблетка, содержащая цетиризин и псевдоэфедрин
KR102479497B1 (ko) 바레니클린 서방성 제제 및 이의 제조 방법
JP5680412B2 (ja) レオヌリンの使用およびその組成物
JP2002504138A (ja) ロシグリタゾンおよびインスリンを用いる糖尿病の治療
WO2011149110A1 (en) Novel composition for the prevention and/or treatment of thromboembolism
JPH0564124B2 (en:Method)
JP3007992B2 (ja) （ｒ）−アムロジピンによる平滑筋細胞の遊走の抑制
JP3576806B2 (ja) アンギオテンシン変換酵素阻害剤とカルシウムチャンネル拮抗剤との固定用量組合せ、製造法、および心血管病の治療におけるその用途
JP2007519646A (ja) 体重の持続的低減のための化合物
KR930001105B1 (ko) 심부정맥 예방 또는 치료용약제
US20080234285A1 (en) Combination of Organic Compounds
KR20030024877A (ko) 중독성 질환의 치료용 화합물
JP4741131B2 (ja) 低血圧およびショックの治療または予防
HU196125B (en) Process for producing pharmaceutical comprising 3-(aminopropoxy)-indole derivatives combined with diuretic
JPS61172820A (ja) カルシウム拮抗剤
JP2636265B2 (ja) 脳循環改善剤
HU206612B (en) Process for producing antihypertenzive combinative composition
KR20070104913A (ko) 2형 당뇨병의 예방 및 치료에 사용될 수 있는 약제의제조를 위한 리모나반트의 용도
JPH02200632A (ja) 医薬組成物
WO2011137601A1 (zh) 左旋氨氯地平复方药物制剂